Cunningham Melissa S, Skrastins Emily, Fitzpatrick Ryan, Jindal Priya, Oneko Olola, Yeates Karen, Booth Christopher M, Carpenter Jennifer, Aronson Kristan J
Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada.
Faculty of Medicine, Queen's University, Kingston, Ontario, Canada.
BMJ Open. 2015 Mar 10;5(3):e005828. doi: 10.1136/bmjopen-2014-005828.
To determine cervical cancer screening coverage and the knowledge, attitudes and barriers toward screening tests among women in rural and urban areas of Tanzania, as well as explore how they view the acceptability of the HPV vaccine and potential barriers to vaccination.
A cross-sectional study using interview-administered questionnaires was conducted using multistage random sampling within urban and rural areas in Kilimanjaro Region, Tanzania.
Women aged 18-55 were asked to participate in the survey. The overall response rate was 97.5%, with a final sample of 303 rural and 272 urban dwelling women.
Descriptive and simple test statistics were used to compare across rural and urban strata. Multivariate logistic regression models were used to estimate ORs and 95% CIs.
Most women (82%) reported they had heard of cervical cancer, while self-reported cervical cancer screening among women was very low (6%). In urban areas, factors associated with screening were: older age (OR=4.14, 95% CI 1.86 to 9.24 for ages 40-49, and OR=8.38, 95% CI 2.10 to 33.4 for >50 years), having health insurance (OR=4.15, 95% CI 1.52 to 11.4), and having knowledge about cervical cancer (OR=5.81, 95% CI 1.58 to 21.4). In contrast, among women residing in rural areas, only condom use (OR=6.44, 95% CI 1.12 to 37.1) was associated with screening. Women from both rural and urban areas had low vaccine-related knowledge; however, most indicated they would be highly accepting if it were readily available (93%).
The current proportion of women screened for cervical cancer is very low in Kilimanjaro Region, and our study has identified several modifiable factors that could be addressed to increase screening rates. Although best implemented concurrently, the availability of prophylactic vaccination for girls may provide an effective means of prevention if they are unable to access screening in the future.
确定坦桑尼亚城乡地区女性的宫颈癌筛查覆盖率以及她们对筛查检测的知识、态度和障碍,同时探讨她们对人乳头瘤病毒(HPV)疫苗可接受性的看法以及疫苗接种的潜在障碍。
在坦桑尼亚乞力马扎罗地区的城乡地区,采用多阶段随机抽样方法,通过访谈问卷进行了一项横断面研究。
邀请18 - 55岁的女性参与调查。总体回应率为97.5%,最终样本包括303名农村女性和272名城市女性。
使用描述性和简单检验统计量对农村和城市分层进行比较。采用多变量逻辑回归模型估计比值比(OR)和95%置信区间(CI)。
大多数女性(82%)报告称听说过宫颈癌,而女性自我报告的宫颈癌筛查率非常低(6%)。在城市地区,与筛查相关的因素有:年龄较大(40 - 49岁,OR = 4.14,95% CI为1.86至9.24;50岁以上,OR = 8.38,95% CI为2.10至33.4)、拥有医疗保险(OR = 4.15,95% CI为1.52至11.4)以及了解宫颈癌知识(OR = 5.81,95% CI为1.58至21.4)。相比之下,在农村地区居住的女性中,只有使用避孕套(OR = 6.44,95% CI为1.12至37.1)与筛查相关。城乡地区的女性对疫苗相关知识了解程度都较低;然而,大多数表示如果疫苗容易获得,她们会非常愿意接种(93%)。
在乞力马扎罗地区,目前接受宫颈癌筛查的女性比例非常低,我们的研究确定了几个可改变的因素,解决这些因素可能会提高筛查率。虽然预防性疫苗接种最好与筛查同时实施,但如果女孩未来无法获得筛查,那么为她们提供预防性疫苗接种可能是一种有效的预防手段。